Bioventus Focused on Integrating Recent Acquisitions

Bioventus reported 4Q21 orthopedic sales of $122.1 million, +23.9% vs. 4Q20. For the full year, the company generated $413.2 million in orthopedic sales, +28.6% vs. the prior year.

Bioness and Misonix, both acquired in 2021, helped the company expand into new verticals. Bioventus generated +5% organic growth in the fourth quarter and +19%...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us